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Abstract
Introduction: Brand's four reasons for clinical tests and his analysis of the characteristics of valid
biomechanical tests for use in orthopaedics are taken as a basis for determining what
methodologies are required for gait analysis in a clinical rehabilitation context.
Measurement methods in clinical gait analysis: The state of the art of optical systems capable
of measuring the positions of retro-reflective markers placed on the skin is sufficiently advanced
that they are probably no longer a significant source of error in clinical gait analysis. Determining
the anthropometry of the subject and compensating for soft tissue movement in relation to the
under-lying bones are now the principal problems. Techniques for using functional tests to
determine joint centres and axes of rotation are starting to be used successfully. Probably the last
great challenge for optical systems is in using computational techniques to compensate for soft
tissue measurements. In the long term future it is possible that direct imaging of bones and joints
in three dimensions (using MRI or fluoroscopy) may replace marker based systems.
Methods for interpreting gait analysis data: There is still not an accepted general theory of
why we walk the way we do. In the absence of this, many explanations of walking address the
mechanisms by which specific movements are achieved by particular muscles. A whole new
methodology is developing to determine the functions of individual muscles. This needs further
development and validation. A particular requirement is for subject specific models incorporating
3-dimensional imaging data of the musculo-skeletal anatomy with kinematic and kinetic data.
Methods for understanding the effects of intervention: Clinical gait analysis is extremely
limited if it does not allow clinicians to choose between alternative possible interventions or to
predict outcomes. This can be achieved either by rigorously planned clinical trials or using
theoretical models. The evidence base is generally poor partly because of the limited number of
prospective clinical trials that have been completed and more such studies are essential. Very
recent work has started to show the potential of using models of the mechanisms by which people
with pathology walk in order to simulate different potential interventions. The development of
these models offers considerable promise for new clinical applications of gait analysis.
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For the purposes of this paper gait analysis will be assumed
to refer to the instrumented measurement of the move-
ment patterns that make up walking and the associated
interpretation of these. The core of most contemporary
gait analysis is the measurement of joint kinematics and
kinetics. Other measurements regularly made are electro-
myography (EMG), oxygen consumption and foot pres-
sures. A systematic physical examination of the patient is
usually conducted as part of a gait analysis.
Rehabilitation is a clinical discipline and this paper will
thus concentrate on clinical gait analysis. Richard Brand
[1,2] proposed four reasons for performing any clinical
test (see Table 1). The third of these might actually be
taken as a definition of the word clinical i.e. a clinical test
is one conducted in order to select from among different
management options for a patient (including the possibil-
ity of not intervening).
Much contemporary gait analysis is done for the purpose
of clinical research. This differs from clinical testing in that
the reason is not to make clinical decisions for the individ-
ual patient, but to learn about a condition affecting a
group of patients or the effect of an intervention. It is
important to remember that the criteria for valid clinical
research may not be the same as those for valid clinical
testing. For example if a measurement made on a patient
cannot be relied upon because of random errors then that
measurement will not be useful for clinical purposes. By
increasing the number of patients in a sample however,
even measurements with quite large random errors can
result in meaningful conclusions in clinical research. This
paper will focus on gait analysis for clinical use. It will also
focus on methodology rather than areas of clinical appli-
cation.
Brand's [1,2] other three possible reasons for performing
any clinical test are to distinguish between disease entities
(diagnosis), to determine the severity, extent or nature of
a disease or injury (assessment), and to predict outcomes
of intervention (or the absence of intervention). The mon-
itoring of the progress of a patient's condition either fol-
lowing intervention or in its absence might be regarded as
an additional reason. This modification of Brand's
approach is summarised in Table 2.
Brand went on to propose a number of criteria for assess-
ing the usefulness of biomechanical measurements in
general which, with some modification, can be used as cri-
teria for the usefulness of all clinical gait analysis. These
are listed in Table 3. The first requirement of any clinical
measurement is that it should characterise the patient,
that is if the patient attends on two separate occasions,
between which his or her condition might be considered
as stable, the measurements taken should be similar. This
requires that the measurement technique itself is repeata-
ble but also that the quantity being measured is stable and
independent of factors such as mood, motivation or pain.
Measurements can be repeatable and stable without nec-
essarily being accurate (representative of a specific physi-
cal quantity). Such tests can be clinically useful but will be
much easier to interpret if they are also accurate. In an era
of evidence based clinical practice it is essential that any
measurement techniques are appropriately validated
which must include assessments of both their repeatabil-
ity and accuracy.
In order to perform a diagnostic function it is necessary
for measurements to be able to distinguish normal from
abnormal patterns of movement and also between the
characteristics of one disease entity and another. There are
two aspects to this. The first is having measurement sys-
tems capable of working to adequate precision. The sec-
ond is a knowledge of what characterises normal walking
or a particular disease entity.
The requirement for patient assessment pre-supposes that
a diagnosis does not give sufficient information to deter-
mine the most appropriate management for a patient and
that measuring the precise characteristics of a patient's
condition are essential for this. Measurements thus have
to be sufficiently precise to reveal clinically important dif-
ferences between patients with the same diagnosis. For
monitoring purposes measurements need to be suffi-
ciently precise to be able to determine whether a patient's
condition is stable, improving or deteriorating.
Brand suggested that the measurement technique should
not affect the function it is measuring. The walking per-
Table 2: Reasons performing clinical gait analysis (modified from 
Brand [1, 2])
Clinical gait analysis is performed to allow the selection from amongst 
treatment options (including the possibility of not intervening). This is 
based on one or more of:
1. Diagnosis between disease entities.
2. Assessment of the severity, extent or nature of a disease or injury.
3. Monitoring progress in the presence or absence of intervention.
4. Prediction of the outcome of intervention (or the absence of 
intervention).
Table 1: Reasons performing clinical tests as stated by Brand [1, 
2])
1. to distinguish Diagnosis between disease entities (diagnosis).
2. to determine severity of disease or in jury (i.e. assessment or 
evaluation)
3. to select among treatment options
4. to predict prognosisPage 2 of 10
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patient concentrating on what they are doing in an ideal-
ised environment, is not necessarily representative of their
normal walking. At the very least this must be taken into
account when interpreting results.
Gait analysis should reveal information that is useful to
the clinician and this will generally require that results are
reported in terms analogous to accepted clinical concepts.
It must be cost-effective, that is the benefit of performing
the test must be worth the cost. This balance need not nec-
essarily be determined in purely financial terms but the
financial cost of gait analysis is a significant factor. Finally
there is no point doing any clinical test if the results could
be obtained sufficiently well by simply observing the
patient
The information obtained by assessing the patient is that
used for selecting management options. This process does
not, therefore, make further demands on the measure-
ment systems but does require an understanding of how
the patient's condition is likely to be affected by an inter-
vention (or none) to a level sufficient to determine which
options are preferable. Prediction of outcomes takes this
one stage further to being able to determine not only
which management option is best but also how the
patient will be after that intervention.
This sequential analysis of the four potential purposes of
clinical tests reveals a progression from just requiring reli-
able and precise measurements to the additional require-
ment of having an understanding of how such
information is incorporated into clinical practice. The
state of the art is that the measurement component of gait
analysis can reasonably be described as an objective proc-
ess whereas the interpretation component is predomi-
nantly subjective.
Making the interpretive component more objective can be
achieved in two ways. The first is to develop a general the-
ory of how people walk whether they have recognised
pathology or not. As long ago as 1982 Cappozzo
lamented, "The approaches to clinical gait analysis and
evaluation are not supported by general theories" [3] and
despite over 20 years of intense activity this is still a rea-
sonable summary of the state of the art. The second
approach, which must operate in the absence of the
former, is to conduct clinical research to ascertain the out-
come of particular interventions on groups of patients
characterised by certain measurements. Most of the
knowledge base used in the interpretive component of
gait analysis comes from such studies. It is because there
are relatively few studies available to base such interpreta-
tions on that the subjective element of interpretation is
necessary in contemporary clinical gait analysis.
Measurement methods in clinical gait analysis
Modern clinical gait analysis traces its origins back to the
early 1980s with the opening of the laboratory developed
by the United Technologies Corporation at Newington,
Connecticut and those provided with equipment by
Oxford Dynamics (later to become Oxford Metrics) in
Boston, Glasgow and Dundee. Retro-reflective markers
were placed on the skin in relation to bony landmarks.
These were illuminated stroboscopically and detected by
modified video cameras. If two or more cameras detect a
marker and the position and orientation of these cameras
are known then it is possible to detect the three-dimen-
sional position of that marker [4].
Whilst the basic principles remain the same as the earliest
systems, the speed, accuracy and reliability has advanced
beyond all recognition. It is not uncommon now to find
clinical systems using 8, 10 or more cameras functioning
at over 100 Hz and capable of detecting reliably the pres-
ence of many tens of markers of between 9 and 25 mm
diameter. Calibration of the systems (the determination
of the position, orientation and optical and electronic
characteristics of the cameras) can generally be accom-
plished in less than a minute. Marker positions from clin-
ical trials can be reconstructed and markers labelled
automatically in real time (although this feature is often
not essential for clinical studies). The determination of
the accuracy of such systems is now generally limited by
the accuracy of any alternative means to determine marker
position and can be taken to be of the order of 1 mm. This
is probably an order of magnitude smaller than other
sources of error in determining joint kinematics and
kinetics. This particular measurement technology has thus
reached a mature state of development that, whilst
advances will almost certainly continue, already probably
delivers all that is required by conventional gait analysis
[5].
The same cannot be said of the computer models used to
derive joint kinematics and kinetics from the marker posi-
tion data supplied by the measurement hardware. Almost
all commercially available clinical systems use some vari-
ant of the Conventional Gait Model [6] which has been
referred to as the Newington, Gage, Davis [7], Helen
Hayes, Kadaba [8,9] or Vicon Clinical Manager (VCM)
model. This was developed using the minimum number
of markers possible to determine 3-dimensional kinemat-
ics and kinetics [10,11] of the lower limb at a time when
measurement systems were only capable of detecting a
handful of markers. It assumes three degree of freedom
joints for the hip and knee and a two degree of freedom
joint at the ankle. The model is hierarchical requiring the
proximal segments to have been detected in order that dis-
tal segments can be defined and incorporates regression
equations to determine the position of the hip joint centrePage 3 of 10
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using an inverse dynamics approach which generally
requires considerable filtering to give any useful signals.
An alternative system the Cleveland Clinic Model based
around a cluster of markers on a rigid base attached to
each segment is the only other widely used model. Unfor-
tunately documentation of this model in the scientific lit-
erature is very poor.
The problem of limited repeatability
The primary problem of current measurement technology
is that of reliability in routine clinical use. Several studies
have now been reported in which a single subject has been
analysed in a number of different laboratories [12-14].
These have shown a degree of variability between sites
that would appear to be sufficient to undermine clinical
applications. In retrospect, the original studies of the reli-
ability are flawed. There was no such study of the Davis
implementation of the model and the statistics used by
Kadaba et al [8,9] to report reliability of their implemen-
tation probably acted to mask deficiencies. In particular,
use of relative measures of reliability such as the coeffi-
cient of multiple correlation (CMC) makes interpretation
of findings difficult. Almost all reliability studies have
been done on subjects without pathology where marker
placement is reasonably straightforward. Reliability for
clinical populations is rarely reported in the literature and
is almost certainly inferior.
At least one recent study has shown that it is possible to
get levels of reliability sufficient to justify the continued
clinical use of gait analysis within a single centre [15]. Too
few centres however are providing evidence to establish
that this is the rule rather than the exception.
Whilst not the most exciting field of research, a very
real need of clinical gait analysis is for the development
of techniques for establishing the reliability of meas-
urement techniques and of methods of quality assur-
ance that will ensure that the very highest standards of
reliability are achieved in routine clinical practice.
Source of error: Model calibration
There are two principal sources of error. The first is the dif-
ficulty determining the anthropometry of the individual
subject (known as model calibration). This has two aspects,
placing markers accurately with respect to specific ana-
tomical landmarks and determining the location of the
joint centres (and other anatomical features) in relation to
these markers. Failure to place markers accurately is prob-
ably the single greatest contributor to measurement varia-
bility in contemporary clinical gait analysis. This is partly
a matter of appropriate staff training and quality assur-
ance but at least as important, and more fundamental, is
the problem that many of the landmarks used to guide
marker placement are not themselves particularly well
defined in patients with certain conditions [16]. Even
when bony landmarks are sharply defined an increasing
number of patients have a considerable thickness of sub-
cutaneous fat that makes palpation difficult.
The Conventional Gait Model uses regression equations
to determine the position of the hip joint centre in rela-
tion to the pelvis. Both Bell's [17-19] and Davis' [7] equa-
tions are commonly used and there is now good evidence
that neither is satisfactory in healthy adults [20]. There
have still been no published studies of whether either is
valid for healthy children. Children with orthopaedic con-
ditions including cerebral palsy may often have dysplasia
of the hip or deformity of the pelvis, and it is exceedingly
unlikely that any form of regression equation could be
used in these patients to determine hip joint position.
Methods for moving away from anatomical landmarks
and regressions equations for determining joint centres
have been around for nearly a decade, the process being
known as anatomical calibration [21]. They rely on calibra-
tion movements to be performed before capturing walk-
ing data and some form of fitting of the measured marker
positions to an underlying model of how the body moves.
The simplest example is probably the determination of
the hip joint centre. It is assumed that the hip joint moves
as a ball and socket joint about centre of rotation fixed in
the pelvis. Any marker on the femur would thus be
expected to describe a path on the surface of a sphere cen-
tred on the hip joint centre when the hip joint is moving.
A least squares fit of the measured data to such a sphere
allows the location of that joint centre to be determined
[20,22]. Similar approaches are applicable to determine
that axis of the knee joint which for this purpose has often
been assumed to be a simple hinge joint.
Various approaches to fitting data to an underlying model
have been attempted and many seem to give reasonable
results [20,22-28]. Such techniques have not so far been
widely accepted into clinical practice probably because
there is a perception that such calibration trials are too dif-
?
Table 3: Criteria for biomechanical measures (extracted from 
text of Brand [1])
Reproducible
Stable (independent of mood, motivation and pain)
Accurate
Appropriately validated
Capable of distinguishing between normal and abnormal
Must not alter the function it is measuring
Reported in form analogous to accepted clinical concepts
Cost-effective
Not observable by the skilled clinicianPage 4 of 10
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ever has now committed itself to implementing such
techniques into routine practice and has reported failure
to perform test adequately in only one of over 700
patients tested so far.
Further studies are needed to confirm these studies
and to identify which of the range of available optimi-
sation techniques is the best suited to clinical applica-
tions. Comprehensive reliability studies are again
needed to demonstrate the advantages of using such
models over the conventional model.
Sources of error: Soft tissue artefact
The second source of error is the degree of movement of
the skin, muscle and other soft tissues in relation to the
bones that occurs during walking. This is perhaps most
marked in relation to the rotational profile of the hip.
Lamoreux [29], as far back as 1991, reported that with
optimal placement of thigh wands only 65% of transverse
plane hip joint rotation was detected and that with poor
placement this could be as little as 35%.
The problem of skin and other soft tissue movement is
more problematic than that of model calibration. Lu and
O'Connor where the first to propose fitting a model of
how the body is expected to move to marker co-ordinate
data [30] using an optimisation approach. This model
uses a least squares fit, similar to some of the techniques
described above for model calibration, and thus makes no
assumptions about the nature of the soft tissue move-
ment. Other similar models have now been made com-
mercially available [26]. More recent studies have started
to try to map out the movement of markers with respect
to the underlying bones [31,32]. If such movement can be
characterised as a function of joint angle then, in princi-
ple, this knowledge could be built into a model to allow
such movements to be compensated for. Such mapping is
only likely to be useful if it can be shown that soft tissue
movement is consistent across a range of subjects and
activities. It is not clear at present whether these condi-
tions are satisfied. A particular problem in regard to map-
ping soft tissue movement is that of defining what the
"true" movement of the bones is. In the absence of any
gold standard a variety of assumptions are being used
most of which have serious limitations.
Significant work is needed in this area. A gold stand-
ard method for determining joint movement is
required.
Maps of soft-tissue movement as a function of joint
angle are required and work done to establish how
these vary from individual to individual and from task
to task.
Marker sets need to be defined based on the optimum
placement of markers given knowledge of the soft-tis-
sue displacements.
Finally it is possible that knowledge of likely soft-tis-
sue displacement could be built into the optimisation
algorithms allowing for better estimates of the move-
ments of the underlying skeleton.
The development of a gold standard method for deter-
mining joint movement will probably require a move
away from skin-mounted markers (or other sensors).
Once such technology is available however it is quite pos-
sible that this will supersede the presently available sys-
tems. The cost of any such new systems however is likely
to prohibit ready clinical availability in the foreseeable
future.
There has been some work done on markerless optical
methods. By placing a number of video cameras around a
subject and tracing the silhouette of the walking subject
on each it is possible to generate a 3-dimentional silhou-
ette of that subject. This has already been achieved but the
next step of using such a silhouette to determine the co-
ordinate systems associated with the moving body seg-
ments has not yet been satisfactorily achieved.
It is possible that the problem of skin movement can only
be satisfactorily addressed by making direct measure-
ments of bone position. It is now possible to take 3-
dimensional images of bones (and muscles) using MRI
but only within a very restricted capture volume [33-35].
The image processing problem of automatically determin-
ing a bone embedded axis system from such images has
yet to be solved satisfactorily. Similarly both uniplanar
and biplanar cine fluoroscopy [36-40] has been used to
detect the 3-dimensional movement of the internal knee
prostheses during a variety of movements. This is possible
because a knowledge of the exact size and shape of the
prosthetic components and their opacity to x-rays greatly
simplifies the image processing problem. Using similar
techniques to determine the movement of joints has also
been reported [41-43]
Using 3-dimensional imaging techniques to directly
determine bone movements during walking either as a
technology with potential clinical applicability or for
use as a gold reference standard from which to improve
?
?
?
?
?
?Page 5 of 10
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nologies is one of the greatest challenges in this area.
Methods for interpreting clinical gait analysis 
data
The second element of clinical gait analysis is the interpre-
tation of data. Conventions for describing 3-dimensional
joint kinematics and kinetics are well formulated. Many
laboratories are augmenting conventional kinematics and
kinetics with muscle length and, less commonly, moment
arm graphs. Normal patterns of movement as represented
by these data are now generally fairly well understood by
clinical specialists although there is actually very little nor-
mative data published in the peer-reviewed literature.
Similarly, many abnormal patterns of movement are quite
widely recognised by clinicians but there few published
attempts at formal classification of these [44-46]. Many
clinicians have learnt to associate particular abnormal pat-
terns in particular patient groups with particular impair-
ments of body structure and function. Intervention based
on such an understanding often leads to a normalisation
of gait patterns at subsequent assessments (e.g. [47-55]).
It is on this basis that clinical gait analysis operates at
present.
Despite the widespread acceptance of many of these con-
ventions there are still problems. Baker [56] demonstrated
that the Euler sequence used to calculate pelvic angles
gives rise to data that can be mis-leading to clinicians and
proposed an alternative to correct this which is yet to be
adopted widely within clinical analysis. Methods for inter-
preting angles in three dimensions, either in terms of
Euler/Cardan rotations or the Grood and Suntay conven-
tion [57,58] are not well understood either by clinicians
or many bioengineers. A recent attempt to standardise the
reporting of joint angles [59] proposed a different conven-
tion to that of the Conventional Gait Model and the con-
tinuing debate as to which is preferable illustrates this
confusion [60,61]. Joint moments are generally reported
with reference to orthogonal axis systems fixed in the dis-
tal (Conventional Gait Model) or proximal segments (or
occasionally the laboratory axis system). These differ sig-
nificantly depending on the axis system chosen [6,62] yet
there has been no debate about which if any is preferable.
Reporting moments about orthogonal axis systems and
joint rotations about non-orthogonal ones leads to diffi-
culties in relating the moments to the changes in joint
angles to which they are related. The use of muscle
moment arms will be discussed further below but it is
interesting that there is no straightforward definition of
the meaning of the term moment arm in three dimensions
[63] and it is often not clear how such data should be
interpreted.
A consistent, comprehensive and clear method for
describing joint kinematics and kinetics in three
dimensions would be of immense benefit for the clini-
cal gait analysis community.
Perhaps the most important limitation of our present
understanding of human walking, however, is that it is
primarily descriptive. We know what happens rather than
why it happens. Many in the clinical gait analysis commu-
nity regard kinematics as descriptive but contend that
kinetics explain movement patterns. This is almost cer-
tainly misguided. Kinetics are simply another set of meas-
urements and can thus only be descriptive.
There have been various attempts at establishing a theory
of walking but none is particularly convincing. Saunders,
Inman and Eberhart's determinants of normal walking
[64] are perhaps the best known of these. Recent publica-
tions however have questioned how the detail of these
reflects experimental data [65-70]. Gage [71,72] based his
pre-requisites of gait on earlier work by Perry [73] but
these are best regarded as pointers to where particular
patients are deficient rather than explanations of how they
are achieving walking with or without pathology.
Perhaps the closest we have come so far to understanding
why we walk the way we do has come from the work of
Pandy and Anderson [74,75]. They have shown that it is
possible to construct a mathematical simulation of mus-
cle function during normal walking based on the assump-
tion that the total consumption of energy per unit
distance walked is minimised. The authors, however,
commented that the model seems more dependent on the
boundary conditions imposed than on the nature of the
optimisation function. Further, because of the complex
nature of the optimisation process driving the model it is
still difficult to explain how the precise characteristics of
any particular feature of the walking pattern affect the
overall calculation of energy expenditure. So far such a
model has only been constructed for normal walking.
An obvious challenge in the emerging field of compu-
tational biomechanics is to apply similar techniques to
model walking with particular forms of pathology.
Conceptually, modifying such models to incorporate a
specific abnormality of the musculo-skeletal anatomy
such as a leg length discrepancy or contracture of a partic-
ular muscle is reasonably straightforward. It is much less
certain whether such techniques can be applied at all to
patients with neuromuscular pathology who are most fre-
quently seen by clinical gait analysis services. Optimisa-
tion techniques assume that movements are controlled in
such a way that a specific control function is minimised.
?
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kinson's disease, adult hemiplegia) the problem is one of
a loss of central control and this would appear to invali-
date any techniques modelling human movement as an
optimised process.
If such models are developed it will be interesting to see
whether they give any insights into the clinical manage-
ment of patients. Further it will be interesting to see
whether their use leads to an understanding of why we
walk the way we do which can be formulated as theories
that are applicable without the use of such complex mod-
els.
Perhaps the greatest challenge in clinical gait analysis
is still to answer the question. "Why do we walk the way
we do and why don't our patients?".
Whilst the answer to this question still seems as far away
as ever, significant advances have been made over recent
years in understanding the mechanisms by which we walk
particularly in the way that muscles act. For many years it
was assumed that a muscle's anatomical position deter-
mines how it acts. It was assumed for example that the
action of the hamstrings, passing behind the knee, was
always to flex the knee. It is only comparatively recently
that biomechanists have come to appreciate that any indi-
vidual muscle has an effect on all the segments of the
body and that in some circumstances this may result in a
muscle having an action different to its anatomical func-
tion [76-81]. It is now fairly well accepted, for example,
that the hamstrings functions as a knee extensor during
early stance in normal walking because its effect in extend-
ing the hip has a secondary tendency to extend the knee
which is greater than its direct effect as an anatomical knee
flexor [82].
Such work depends on knowing the joint kinematics and
kinetics and inertial properties of the body segments.
These can be used to estimate the forces in individual
muscles [81-83]. This is an indeterminate problem so is
dependent on an optimisation approach (and the validity
of this in neuromuscular pathology is questioned in the
same way as that of the simulations described above).
Once the muscle forces are known forward modelling can
be used to determine the effect that a given muscle is hav-
ing on any segment (or joint) of the body. Until very
recently the first part of this problem, the estimation of
muscle forces had not been achieved which limited the
application of the second part, the forward modelling to
data obtained from the simulations described above
[74,75]. Recently methods have been develop to estimate
the muscle forces required to generate measured joint kin-
ematics and ground reaction forces and have been used
both to understand the function of individual muscles
during pathological gait and predict the effect of interven-
tions [84,85]. These have been based on scaled models of
the adult musculo-skeletal anatomy.
A further area of challenge is in using 3-dimensional
imaging techniques to model musculo-skeletal deform-
ities to allow the generation of patient-specific models of
walking.
There is also considerable debate at present about the
validity of these techniques (the simulations, the estima-
tions of muscle forces and the forward modelling). Whilst
the general principles are sound the techniques are known
to be extremely sensitive to certain aspects of their imple-
mentation (and may be sensitive to many more). For
example the forward modelling in particular is sensitive to
how the interaction between the foot and the floor is
modelled with there being no clear consensus as to the
most appropriate method for this [74,77,81].
Implementation of these models must be based on
robust techniques being developed to validate models,
the first step of this is in rigorous analysis of the sensi-
tivity of models to the assumptions on which they are
based.
Methods for understanding the effect of 
intervention
Understanding how to interpret clinical gait analysis data
is not itself sufficient to allow selection from amongst
treatment options (Table 1). For this it is also necessary to
know what effect the available interventions are likely to
have on someone's walking pattern. If we had a general
theory of walking then it might be possible to develop a
theoretical basis for considering the effect of any interven-
tion. For patients whose walking could be modelled using
a simulation based on specific musculo-skeletal abnor-
malities it might be possible to use similar simulations to
model what might happen if partial correction of those
abnormalities were attempted (obviously full correction
would restore normal walking!). The author is unaware of
any published work at this level at present.
There are then two methods for understanding the effects
of intervention in these patients; clinical research to estab-
lish what the actual effect of a given intervention is or
using knowledge of the mechanisms of walking to predict
the effect of modifying the characteristics of the musculo-
skeletal anatomy.
By far the most common approach to date has been the
use of clinical research – the comparison of gait patterns
before and after a particular intervention [47-55,86-88].
?
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have given conclusive findings. Many studies which claim
to have done so have quite serious methodological flaws.
This is particularly true of research into orthopaedic sur-
gery for children with CP where researchers have used ret-
rospective audits of clinical practice to try and answer
specific questions. Many of these studies attempt to make
inferences about individual procedures which have only
ever been performed as part of a multi-level surgical pack-
age [47,49-51,54,55]. It is impossible to tell from these
studies which effects are due to the particular procedure
being considered and which are due to the overall pack-
age. Several studies have attempted to separate out those
effects by dividing patients into those who have and those
who have not had a particular procedure as part of the
overall package of surgery and use methods to compare
groups similar to those that would be used for a ran-
domised clinical trial [47,54]. The validity of this
approach is questionable, however, because generally the
two groups of patients were not similar to start with.
Those that had the procedure had it because it was consid-
ered that the patient needed it and vice versa. Comparison
of the two groups to give insight into the effect of the pro-
cedure is thus invalid.
Perhaps the most challenging field of research for
clinical gait analysis is in the design and conduct of
prospective clinical trials to ascertain the effects of spe-
cific treatments on specific patient groups.
An alternative to the use of clinical trials is to use knowl-
edge of the mechanisms of walking as a basis for model-
ling the effect of changing that mechanism. Reports of
such studies are now starting to emerge. For example
Arnold et al. [84] have reported a subject specific model of
a cerebral palsy patient with a stiff knee gait and used it to
predict the effect of three different potential interventions.
These indicated a preferable intervention and the post-
intervention gait data showed at least qualitative agree-
ment with the theoretical predictions.
Application of such techniques to a wider range of
clinical problems represents another exciting sphere of
research in clinical gait analysis. It may well be that
such techniques are limited to the fairly narrow range
of interventions that are based on correction of the
mechanisms for very specific aspects of walking but
identifying the range of potential applications will be
an important part of this process.
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